Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCG in bladder cancer

D Meek

    Nursing Times
    |October 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Bacillus Calmette-Guérin (BCG) vaccine, commonly known for tuberculosis prevention, is explored as an alternative to traditional cytotoxic agents for treating bladder cancer. This research highlights its potential in cancer therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone.

    European journal of radiology·2021
    Same author

    Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder.

    Translational psychiatry·2017
    Same author

    Assessment and Optimisation of Lung Cancer Patients for Treatment with Curative Intent.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2016
    Same author

    Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering.

    Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2011
    Same author

    Colorectal liver metastases.

    Annals of the Royal College of Surgeons of England·2009
    Same author

    Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2009
    Same journal

    'The little things count': delivering dignified care.

    Nursing times·2018
    Same journal

    The heart of the hospital.

    Nursing times·2018
    Same journal

    The nurse's role in caring for people with dementia.

    Nursing times·2018
    Same journal

    Hepatitis C and the ongoing challenge of genotype 3.

    Nursing times·2018
    Same journal

    Implementing change in older people's acute care.

    Nursing times·2018
    Same journal

    A total health economy approach to revalidation.

    Nursing times·2018
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Urology

    Background:

    • Bacillus Calmette-Guérin (BCG) is widely recognized as a vaccine for tuberculosis.
    • Current standard treatments for bladder cancer often involve cytotoxic agents, which can have significant side effects.

    Purpose of the Study:

    • To investigate the efficacy of Bacillus Calmette-Guérin (BCG) as an alternative therapeutic agent for bladder cancer.
    • To evaluate BCG's potential to replace or supplement conventional cytotoxic chemotherapy in bladder cancer treatment.

    Main Methods:

    • Review of existing literature on BCG immunotherapy for bladder cancer.
    • Analysis of clinical data comparing BCG treatment with cytotoxic agents.
    • Exploration of the immunological mechanisms underlying BCG's anti-tumor effects in the bladder.

    Related Experiment Videos

    Main Results:

    • BCG demonstrates significant potential as a treatment modality for bladder cancer.
    • Evidence suggests BCG can be an effective alternative to cytotoxic drugs, potentially offering a different side-effect profile.
    • The immunomodulatory properties of BCG contribute to its anti-cancer activity.

    Conclusions:

    • Bacillus Calmette-Guérin (BCG) presents a viable alternative to cytotoxic agents in bladder cancer treatment.
    • Further research into BCG immunotherapy can optimize its application and expand its role in urologic oncology.